Madison #39;s Before After Stem Cell Therapy
Had step cell therapy procedure on 4/14/14 and we were seeing noticeable results only 4 short days later.
By: Jaie Locke
Follow this link:
Madison's Before & After Stem Cell Therapy - Video
Tuesday, April 22 11:57:06
Orbsen Therapeutics, a spin-out from NUI Galway's Regenerative Medicine Institute (REMEDI), is to partner with the University of Birmingham in a E6 million EU FP7 funded MERLIN project to fight liver disease.
The EU FP7-funded project known by the acronym "MERLIN" (MEsynchymal stem cells to Reduce Liver INflammation) is led by Professor Phil Newsome, Clinical Director of the Birmingham University Stem Cell Centre. MERLIN will advance Orbsen's proprietary cell therapy to a Phase 2a clinical trial in patients with inflammatory liver disease. This MERLIN project will evaluate the Orbsen cell therapy in 4 different research laboratories across Europe and the project will culminate in a Phase 2a clinical trial of the therapy in the crippling inflammatory liver disease, Primary Sclerosing Cholangitis.
This is Orbsen's fourth success in attracting FP7 funding (the EU's Seventh Framework Programme for Research), making them one of Ireland's most successful private companies in this funding programme and now connects Orbsen to 23 global collaborators. Other successful cell therapy projects for Orbsen include PURSTEM (completed), REDDSTAR (ongoing) and DeCIDE (ongoing).
Orbsen Therapeutics Ltd. is a privately-held company founded in 2006 as a spin-out from Ireland's Regenerative Medicine Institute (REMEDI) in NUI Galway. As part of the PurStem EU FP7 program, Orbsen developed proprietary technologies that enable the prospective purification of highly defined and therapeutic (stromal) cells from several human tissues, including bone marrow, adipose tissue and umbilical cord.
Orbsen's CEO Brian Molloy said, "Orbsen has secured substantial amounts of research funding in the last 18 months which will further validate our product and bring us through to a "first in man" clinical trial in 2015/16. Our model has always focused on putting the 'science first' and we have successfully used that approach to develop a technology that could potentially position us and indeed Ireland at the leading edge of European Cell Therapy development."
Mr Molloy continued, "As a spin-out from the NUI Galway based REMEDI Institute we have focused the majority of our collaborations with an Irish research team. Our success in the MERLIN project now demonstrates that we are capable of playing a key role in collaborations led by researchers across Europe."
The total research budget for the MERLIN project is close to E6 Million of which E1 Million will go directly to Orbsen Therapeutics over the 4-year period of the project.
Continue reading here:
Irish cell therapy firm in E6m research
Stem Cells in Anti-Aging Medicine: Workshop Preview
By: A4MEvents
See original here:
Stem Cells in Anti-Aging Medicine: Workshop Preview - Video
Scientists Create Stem Cells From Adult Skin Cells
The breakthrough could mean a cure for some serious diseases and even the possibility of human cloning, but it #39;s all still a way off. Follow Christian Bryant...
By: NewsyScience
More here:
Scientists Create Stem Cells From Adult Skin Cells - Video
Madison #39;s Before After Stem Cell Therapy
Had step cell therapy procedure on 4/14/14 and we were seeing noticeable results only 4 short days later.
By: Jaie Locke
Continued here:
Madison's Before & After Stem Cell Therapy - Video
stem cell therapy treatment for Global Developmental Delay with Severe Mental Retardation
improvement seen in just 3 months after stem cell therapy treatment for Global Developmental Delay with Severe Mental Retardation by dr alok sharma, mumbai, ...
By: Neurogen Brain and Spine Institute
Visit link:
stem cell therapy treatment for Global Developmental Delay with Severe Mental Retardation - Video
stem cell therapy treatment for cerebral palsy with mental retardation with low vision by dr alok
improvement seen in just 3 months after stem cell therapy treatment for cerebral palsy with mental retardation with low vision by dr alok sharma, mumbai, ind...
By: Neurogen Brain and Spine Institute
Read the original here:
stem cell therapy treatment for cerebral palsy with mental retardation with low vision by dr alok - Video
PUBLIC RELEASE DATE:
20-Apr-2014
Contact: Krista Conger kristac@stanford.edu 650-725-5371 Stanford University Medical Center
STANFORD, Calif. A single type of cell in the lining of the bladder is responsible for most cases of invasive bladder cancer, according to researchers at the Stanford University School of Medicine.
Their study, conducted in mice, is the first to pinpoint the normal cell type that can give rise to invasive bladder cancers. It's also the first to show that most bladder cancers and their associated precancerous lesions arise from just one cell, and explains why many human bladder cancers recur after therapy.
"We've learned that, at an intermediate stage during cancer progression, a single cancer stem cell and its progeny can quickly and completely replace the entire bladder lining," said Philip Beachy, PhD, professor of biochemistry and of developmental biology. "All of these cells have already taken several steps along the path to becoming an aggressive tumor. Thus, even when invasive carcinomas are successfully removed through surgery, this corrupted lining remains in place and has a high probability of progression."
Although the cancer stem cells, and the precancerous lesions they form in the bladder lining, universally express an important signaling protein called sonic hedgehog, the cells of subsequent invasive cancers invariably do not a critical switch that appears vital for invasion and metastasis. This switch may explain certain confusing aspects of previous studies on the cellular origins of bladder cancer in humans. It also pinpoints a possible weak link in cancer progression that could be targeted by therapies.
"This could be a game changer in terms of therapeutic and diagnostic approaches," said Michael Hsieh, MD, PhD, assistant professor of urology and a co-author of the study. "Until now, it's not been clear whether bladder cancers arise as the result of cancerous mutations in many cells in the bladder lining as the result of ongoing exposure to toxins excreted in the urine, or if it's due instead to a defect in one cell or cell type. If we can better understand how bladder cancers begin and progress, we may be able to target the cancer stem cell, or to find molecular markers to enable earlier diagnosis and disease monitoring."
Beachy is the senior author of the study, which will be published online April 20 in Nature Cell Biology. He is the Ernest and Amelia Gallo Professor in the School of Medicine and a member of the Stanford Cancer Institute and the Stanford Institute for Stem Cell Biology and Regenerative Medicine. He is also a Howard Hughes Medical Institute investigator. Kunyoo Shin, PhD, an instructor at the institute, is the lead author.
Bladder cancer is the fourth most common cancer in men and the ninth most common in women. Smoking is a significant risk factor. There are two main types of the disease: one that invades the muscle around the bladder and metastasizes to other organs, and another that remains confined to the bladder lining. Unlike the more-treatable, noninvasive cancer which comprises about 70 percent of bladder cancers the invasive form is largely incurable. It is expensive and difficult to treat, and the high likelihood of recurrence requires ongoing monitoring after treatment.
Follow this link:
Stanford scientists identify source of most cases of invasive bladder cancer
Ankle arthritis; 4 months after stem cell therapy by Dr Harry Adelson
Craig discusses his results from his stem cell therapy by Dr Harry Adelson for his arthritic ankle http://www.docereclinics.com.
By: Harry Adelson, N.D.
Originally posted here:
Ankle arthritis; 4 months after stem cell therapy by Dr Harry Adelson - Video
Stem Cells Founder Dr. Newman
Any clue to ageing problem http://www.howtolookyoungertip.jeunesseglobal.com.
By: howtolook youngertips
See the rest here:
Stem Cells Founder Dr. Newman - Video
Bone Marrow Stem Cells Help TBI Case! See the Amazing Before After Results!
Dr. Steenblock treated John F. for a TBI. John suffered from a TBI or a traumatic brain injury after a bike accident. He had just one bone marrow stem cell t...
By: David Steenblock
Continued here:
Bone Marrow Stem Cells Help TBI Case! See the Amazing Before & After Results! - Video
Dr. Al-Towerki speaking about the successful stem cells operation
Dr. Al-Towerki on Saudi TV Dr. Al-Towerki on Saudi TV channel speaking about the successful stem cells operation at King Khaled Eye Specialist Hospital.
By: KKESH
Read the rest here:
Dr. Al-Towerki speaking about the successful stem cells operation - Video
Regenerative Medicine, Younger skin, hair regrowth, PRP, stem cells, stretch marks
This presentation discuss using your own cells and platelets to regenerate your body for a healthier and younger you, whether it is for your face, neck, hand...
By: BangkokStemCells
Excerpt from:
Regenerative Medicine, Younger skin, hair regrowth, PRP, stem cells, stretch marks - Video
Why Integrative Medicine and Stem Cell Treatment
Dr. Michael Belich of Integrative Medical Clinics talks about Integrative Medicine and Stem Cell Treatment. For more detailed information go to http://www.in...
By: Integrative Medical Clinics
Follow this link:
Why Integrative Medicine and Stem Cell Treatment - Video
Sweet Science Lesson! See How Stem Cell Therapy Works
http://www.innovationsstemcellcenter.com Call: 214.420.7970 Facebook: https://www.facebook.com/innovationsmedical Twitter: https://twitter.com/dallasdrj Inst...
By: dallasdrj
Continued here:
Sweet Science Lesson! See How Stem Cell Therapy Works - Video
GTGP Dr Linzey Stem Cell Therapy
By: Mountain Television Network
See the original post here:
GTGP Dr Linzey Stem Cell Therapy - Video
Othropedic Surgeon Dr. Propper Speaks about Stem Cell Therapy - PRP - BMAC
Orthopedic Surgeon Dr. Propper Speaks about the Difference of Stem Cell Injection Therapy PRP - BMAC.
By: Dennis Spoonhour, DC
More:
Othropedic Surgeon Dr. Propper Speaks about Stem Cell Therapy - PRP - BMAC - Video
What Can Be Treated With Stem Cells?
Dr. Michael Belich of Integrative Medical Clinics talks about what injuries, damage or degeneration can be treated with Stem Cells. For more detailed informa...
By: Integrative Medical Clinics
See the rest here:
What Can Be Treated With Stem Cells? - Video
Stem cell scientist Mahendra Rao, former director of the now-defunct Center For Regenerative Medicine at the National Institutes of Health. Photo taken in December, 2013 during a speech by Rao at the World Stem Cell Summit in San Diego.
One of the nation's top stem cell scientists has become an adviser to San Diego's Stemedica, a developer of stem cell-based therapies.
Dr. Mahendra Rao joined Stemedica's scientific and medical advisory board, and will help guide the company's strategy, said Maynard Howe, chief executive of the privately held company. Rao's career as a scientist who has also worked for companies and federal agencies makes him particularly useful, Howe said.
Rao is a medical doctor with a PhD in developmental neurobiology from CalTech. He headed the neurosciences division of the National Institute on Aging. He also led the stem cell division of Carlsbad-based Life Technologies, now a unit of Thermo Fisher Scientific. The two companies are on good terms: Life Technologies sells two kinds of stem cells made by Stemedica, used for research purposes, Howe said.
Rao was most recently founding director of the Center for Regenerative Medicine at the National Institutes of Health, which has been shut down. Rao, who resigned at the end of March, said he was disappointed at the slow pace of funding studies with artificial embryonic stem cells, called induced pluripotent stem cells. Stemedica announced his appointment April 8.
Rao said Wednesday that his goal now is to advance stem cell therapies through the private sector. Stemedica drew his attention because it had developed a method of reliably generating "clinically compliant" stem cells suitable for use in therapy.
In addition, Rao said he likes that Stemedica is developing combination stem cell therapies, using a variety called mesenchymal stem cells. This variety of stem cell generates chemicals that promote short-term regrowth and seems to enhance the survival of other transplanted stem cells. For example, mesenchymal stem cells could help transplanted neural stem cells integrate into the brain.
"That's a high-risk process and it's a much more difficult road, but they seem to be willing to do that," Rao said.
He has also rejoined the board of Q Therapeutics, a Salt Lake City company developing treatments for spinal cord injuries and other neurological disorders. Rao is the company's scientific founder, but had to leave the company when he joined the NIH.
Stemedica and its affiliated companies are undertaking multiple clinical trials of stem cell therapies. One of the most advanced is for stroke, Howe said. See utsandiego.com/stemedicastroke1 for detailed information.
Read the original:
Top stem cell scientist joins Stemedica
Two Central Pennsylvania dogs are receiving a regenerative therapy for arthritis thats unprecedented for this area and less expensive than standard surgery. Stem Cell therapy is a way to repair damaged tissue and treat injury. When dealing with dogs, veterinarians say its the future of treatments and its becoming less costly.
Gunny is a 7-year-old German Shepard. He underwent the revolutionary stem cell therapy at the Palmyra Animal Clinic. Vets say the stem cell therapy is a way to combat Gunnys arthritis in his hips. Doctors collected fatty tissue from his shoulder, processed the stem cells in the lab and injected the cells back into his hips. This happens all in one day for around $1500. Prior to this, surgery could cost around $3,000.
Dr. Calvin Clements of the Palmyra Animal Clinic says, Injected in a damaged joint or ligament, these cells will take on that characteristic and differentiate into the cartilage or tissue were dealing with and help to regenerate it.
Dr. Clements says results are noticeable in about a month. On average, animals improve 85%.
For more information, contact the Palmyra Animal Clinic at 717-838-5451.
To learn more click here.
Link:
Stem Cell therapy on animals may be medicine of the future